219 related articles for article (PubMed ID: 22493296)
21. Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect.
Greineder CF; Brenza JB; Carnemolla R; Zaitsev S; Hood ED; Pan DC; Ding BS; Esmon CT; Chacko AM; Muzykantov VR
FASEB J; 2015 Aug; 29(8):3483-92. PubMed ID: 25953848
[TBL] [Abstract][Full Text] [Related]
22. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
Bajzar L; Nesheim M; Morser J; Tracy PB
J Biol Chem; 1998 Jan; 273(5):2792-8. PubMed ID: 9446587
[TBL] [Abstract][Full Text] [Related]
23. Sequential co-immobilization of thrombomodulin and endothelial protein C receptor on polyurethane: activation of protein C.
Kador KE; Mamedov TG; Schneider M; Subramanian A
Acta Biomater; 2011 Jun; 7(6):2508-17. PubMed ID: 21414427
[TBL] [Abstract][Full Text] [Related]
24. Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor.
Daly C; Qian X; Castanaro C; Pasnikowski E; Jiang X; Thomson BR; Quaggin SE; Papadopoulos N; Wei Y; Rudge JS; Thurston G; Yancopoulos GD; Davis S
Sci Rep; 2018 Jan; 8(1):505. PubMed ID: 29323190
[TBL] [Abstract][Full Text] [Related]
25. Effects of human soluble thrombomodulin on experimental glomerulonephritis.
Ikeguchi H; Maruyama S; Morita Y; Fujita Y; Kato T; Natori Y; Akatsu H; Campbell W; Okada N; Okada H; Yuzawa Y; Matsuo S
Kidney Int; 2002 Feb; 61(2):490-501. PubMed ID: 11849389
[TBL] [Abstract][Full Text] [Related]
26. Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma.
Mohri M; Suzuki M; Sugimoto E; Sata M; Yamamoto S; Maruyama I
Thromb Haemost; 1998 Dec; 80(6):925-9. PubMed ID: 9869162
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro.
Tanaka K; Tawara S; Tsuruta K; Hoppensteadt D; Fareed J
Clin Appl Thromb Hemost; 2018 Sep; 24(6):859-866. PubMed ID: 29683037
[TBL] [Abstract][Full Text] [Related]
28. Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk.
Navarro S; Medina P; Bonet E; Corral J; Martínez-Sales V; Martos L; Rivera M; Roselló-Lletí E; Alberca I; Roldán V; Mira Y; Ferrando F; Estellés A; Vicente V; Bertina RM; España F
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1435-40. PubMed ID: 23520161
[TBL] [Abstract][Full Text] [Related]
29. Platelet factor 4 stimulates thrombomodulin protein C-activating cofactor activity. A structure-function analysis.
Slungaard A; Key NS
J Biol Chem; 1994 Oct; 269(41):25549-56. PubMed ID: 7523387
[TBL] [Abstract][Full Text] [Related]
30. The role of thrombomodulin lectin-like domain in inflammation.
Li YH; Kuo CH; Shi GY; Wu HL
J Biomed Sci; 2012 Mar; 19(1):34. PubMed ID: 22449172
[TBL] [Abstract][Full Text] [Related]
31. Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?
Hohmann JD; Wang X; Krajewski S; Selan C; Haller CA; Straub A; Chaikof EL; Nandurkar HH; Hagemeyer CE; Peter K
Blood; 2013 Apr; 121(16):3067-75. PubMed ID: 23380744
[TBL] [Abstract][Full Text] [Related]
32. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
33. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes.
Grey ST; Hancock WW
J Immunol; 1996 Mar; 156(6):2256-63. PubMed ID: 8690916
[TBL] [Abstract][Full Text] [Related]
34. Humic acid reduces protein-C-activating cofactor activity of thrombomodulin of human umbilical vein endothelial cells.
Yang HL; Hseu YC; Lu FJ; Tsai HD
Br J Haematol; 1998 Apr; 101(1):16-23. PubMed ID: 9576176
[TBL] [Abstract][Full Text] [Related]
35. Bivalent engagement of endothelial surface antigens is critical to prolonged surface targeting and protein delivery in vivo.
Kiseleva RY; Glassman PG; LeForte KM; Walsh LR; Villa CH; Shuvaev VV; Myerson JW; Aprelev PA; Marcos-Contreras OA; Muzykantov VR; Greineder CF
FASEB J; 2020 Sep; 34(9):11577-11593. PubMed ID: 32738178
[TBL] [Abstract][Full Text] [Related]
36. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
Mosnier LO; Elisen MG; Bouma BN; Meijers JC
Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
[TBL] [Abstract][Full Text] [Related]
37. Thrombomodulin improved liver injury, coagulopathy, and mortality in an experimental heatstroke model in mice.
Kawasaki T; Okamoto K; Kawasaki C; Sata T
Anesth Analg; 2014 May; 118(5):956-63. PubMed ID: 24781566
[TBL] [Abstract][Full Text] [Related]
38. Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis.
Isermann B; Hendrickson SB; Zogg M; Wing M; Cummiskey M; Kisanuki YY; Yanagisawa M; Weiler H
J Clin Invest; 2001 Aug; 108(4):537-46. PubMed ID: 11518727
[TBL] [Abstract][Full Text] [Related]
39. Age-dependent vulnerability to endotoxemia is associated with reduction of anticoagulant factors activated protein C and thrombomodulin.
Starr ME; Ueda J; Takahashi H; Weiler H; Esmon CT; Evers BM; Saito H
Blood; 2010 Jun; 115(23):4886-93. PubMed ID: 20348393
[TBL] [Abstract][Full Text] [Related]
40. Exosite 2-Directed Ligands Attenuate Protein C Activation by the Thrombin-Thrombomodulin Complex.
Chen K; Stafford AR; Wu C; Yeh CH; Kim PY; Fredenburgh JC; Weitz JI
Biochemistry; 2017 Jun; 56(24):3119-3128. PubMed ID: 28549218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
